Opportunity ID: 305440
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-18-ARP-CTA |
| Funding Opportunity Title: | DoD Autism Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 21, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 04, 2018 |
| Current Closing Date for Applications: | Oct 04, 2018 |
| Archive Date: | Nov 03, 2018 |
| Estimated Total Program Funding: | $7,500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
The ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. The FY18 ARP Clinical Trial Award seeks applications from all areas of clinical research, and strongly encourages applications that address the critical needs of the ASD community in one or more of the following areas:
• Behavioral, cognitive, and other non-pharmacological therapies
• Pharmacological, genetic, and other biological treatments in ASD
• Dissemination/Implementation of clinically validated interventions
• Therapies to alleviate conditions co-occurring with ASD (i.e., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures)
• Interventions promoting success in key transitions to adulthood for individuals living with ASD
• Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the lifespan and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)
• Improve diagnosis across the lifespan
• Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00242383 | May 21, 2018 | Oct 04, 2018 | View |
Package 1
Mandatory forms
Optional forms
Share This Post, Choose Your Platform!
About the Author: osnqt
